Regeneron Pharmaceuticals Inc (NASDAQ:REGN) (fair value) Par 2%
| Website | https://www.regeneron.com/ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $50,905,915,392 |
| Beta | 0.40579 |
| Average Volume | $1,028,077 |
| Last Dividend | 0% |
| Price on Feb 8, 2021 | $475.17 |
| Autochartist™ Valuation | $483.16 |
| Conclusion |
2% (fair value) |
| Download Report |
